NCT00347932

A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 957 (actual)
• Sponsor: Bausch & Lomb Incorporated · Industry
• Sex: All
• Age: 1 Year
• Healthy volunteers: Not accepted

Summary

Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.

Conditions

• Acute Bacterial Conjunctivitis

Interventions

Type	Name	Description
DRUG	ISV-403	Subjects with bacterial conjunctivitis were randomized to receive 0.6% ISV-403 eye drops three times a day (TID) for 5 days.
DRUG	Vehicle	Subjects with bacterial conjunctivitis were randomized to receive vehicle eye drops three times a day (TID) for 5 days.

Timeline

• Start date: 2006-06-01
• Primary completion: 2007-11-01
• Completion: 2007-11-01
• First posted: 2006-07-04
• Last updated: 2015-03-24
• Results posted: 2009-08-13